A: Docking of the GSTP1 monomer (from chain A of PDB entry 1AQW, represented as a protein surface) and the HPV-16 E7 CR3 dimer (modeled in this study and represented as a protein backbone with the two subunits distinguished by green and orange colors)
Translational Gap: None for the mechanism itself
The HPA axis in major depression: classical theories and new developments
Where they overlap and where they don't Complementary Mechanism Targets Target Origin BPC-157 Gastric juice protein fragment (15 amino acids) TB-500 Thymosin Beta-4 fragment (LKKTETQ region) Target Primary action BPC-157 Local tissue repair signaling TB-500 Systemic cell migration and mobilization Target Angiogenesis BPC-157 VEGF upregulation, NO pathway TB-500 Endothelial migration, VEGF crosstalk Target Cell migration BPC-157 Indirect, via growth factors TB-500 Direct (G-actin sequestering) Target Best-evidence tissue BPC-157 Tendon, gut, gastric mucosa (preclinical) TB-500 Cardiac, corneal, skin (preclinical + early human T4) Target Reported in vivo half-life BPC-157 ~4 hours (animal estimates) TB-500 ~23 days (animal estimates) Half-life figures are pharmacokinetic estimates from animal studies
Research shows that targeting NNMT could help in treating these conditions by improving how the body uses energy, reducing fat, and bettering insulin sensitivity
Independent reviewers consistently note that rodent-model time courses do not transfer one-for-one to humans
